Search research articles
Contact Us
Filters
Showing results (531-540 of 600) with videos related to
Page
of 60
Sort By:
Basic Research in Cardiology
|
March 30, 2022
P2Y<sub>12</sub>-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction
Hana Seung, Jan Wrobel, Carolin Wadle, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 21, 2021
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
Marina Rieder, Nadine Gauchel, Klaus Kaier, et al.
Circulation. Cardiovascular Interventions
|
February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
Mathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions
|
November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial
Mathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Molecular Metabolism
|
May 15, 2021
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe<sup>-/-</sup> mice
Julia Leipner, Tsai-Sang Dederichs, Alexander von Ehr, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 25, 2011
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice
Ingo Hilgendorf, Sara Eisele, Imke Remer, et al.
JAMA Cardiology
|
May 30, 2019
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes
Thomas J Povsic, E Magnus Ohman, Matthew T Roe, et al.
The American Journal of Cardiology
|
December 14, 2002
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone
J Conor O'Shea, Robert G Wilcox, Allan M Skene, et al.
The New England Journal of Medicine
|
December 14, 2016
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C Michael Gibson, Roxana Mehran, Christoph Bode, et al.
Basic Research in Cardiology
|
October 20, 2018
Purinergic receptor Y<sub>2</sub> (P2Y<sub>2</sub>)- dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome
Julian Merz, Philipp Albrecht, Sunaina von Garlen, et al.
Page
of 60
Search research articles
Search
Showing results (531-540 of 600) with videos related to
Sort By:
Page
of 60
Basic Research in Cardiology
|
March 30, 2022
P2Y<sub>12</sub>-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction
Hana Seung, Jan Wrobel, Carolin Wadle, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 21, 2021
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
Marina Rieder, Nadine Gauchel, Klaus Kaier, et al.
Circulation. Cardiovascular Interventions
|
February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
Mathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions
|
November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial
Mathieu Kerneis, Megan K Yee, Roxana Mehran, et al.
Molecular Metabolism
|
May 15, 2021
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe<sup>-/-</sup> mice
Julia Leipner, Tsai-Sang Dederichs, Alexander von Ehr, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 25, 2011
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice
Ingo Hilgendorf, Sara Eisele, Imke Remer, et al.
JAMA Cardiology
|
May 30, 2019
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes
Thomas J Povsic, E Magnus Ohman, Matthew T Roe, et al.
The American Journal of Cardiology
|
December 14, 2002
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone
J Conor O'Shea, Robert G Wilcox, Allan M Skene, et al.
The New England Journal of Medicine
|
December 14, 2016
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C Michael Gibson, Roxana Mehran, Christoph Bode, et al.
Basic Research in Cardiology
|
October 20, 2018
Purinergic receptor Y<sub>2</sub> (P2Y<sub>2</sub>)- dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome
Julian Merz, Philipp Albrecht, Sunaina von Garlen, et al.
Page
of 60